Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | HTR2A | P28223 | 2/20 | 0.31 |
| ▸ | HTR7 | P34969 | 2/20 | 0.31 |
| ▸ | HTR1A | P08908 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | HTR6 | P50406 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | SCN8A | Q9UQD0 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14768630 | 0.89 | ALDH1A1 (0.34) | TYRL3MBTL1ALDH1A1LMNAGAA | |
| SCHEMBL13392637 | 0.85 | TYR (0.36) | TYRALDH1A1LMNAGAAMAPT | |
| SCHEMBL19760409 | 0.82 | TYR (0.38) | TYRL3MBTL1ALDH1A1HTR2AHTR7 | |
| SCHEMBL27396377 | 0.78 | TYR (0.38) | TYRALDH1A1MAPK1SCN8AMEN1 | |
| SCHEMBL21894643 | 0.78 | ANPEP (0.36) | TYRALDH1A1LMNAMEN1KMT2A | |
| SCHEMBL14444135 | 0.77 | TYR (0.39) | TYRLMNAMAPTSCN8A | |
| SCHEMBL15831118 | 0.76 | THRB (0.40) | TYRALDH1A1LMNAGAAMAPT | |
| SCHEMBL1618270 | 0.76 | ALDH1A1 (0.42) | TYRALDH1A1GAAMAPK1SCN8A | |
| SCHEMBL26277706 | 0.75 | TDP1 (0.36) | ALDH1A1LMNAGAAMAPTMAPK1 | |
| SCHEMBL14444133 | 0.75 | PKM (0.41) | TYRALDH1A1LMNAGAASCN8A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240237649-A1 | CRYSTALLINE FORMS OF 5-FLUORO-4-IMINO-3-METHYL-1-TOSYL-3,4-DIHYDROPYRIMIDIN-2-ONE, AND MIXTURES, COMPOSITIONS AND METHODS OF USE THEREOF | ADAMA MAKHTESHIM LTD. (IL) | 2024-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240237649-A1 | CRYSTALLINE FORMS OF 5-FLUORO-4-IMINO-3-METHYL-1-TOSYL-3,4-DIHYDROPYRIMIDIN-2-ONE, AND MIXTURES, COMPOSITIONS AND METHODS OF USE THEREOF | NT5C, RCC1, INF2 | TYR 709/4885L3MBTL1 3501/4885ALDH1A1 2485/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.